Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
2006 1
2009 1
2010 1
2011 1
2012 1
2015 1
2016 3
2017 1
2019 2
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Results by year
Filters applied: . Clear all
Page 1
Immune-mediated ECM depletion improves tumour perfusion and payload delivery.
Yeow YL, Kotamraju VR, Wang X, Chopra M, Azme N, Wu J, Schoep TD, Delaney DS, Feindel K, Li J, Kennedy KM, Allen WM, Kennedy BF, Larma I, Sampson DD, Mahakian LM, Fite BZ, Zhang H, Friman T, Mann AP, Aziz FA, Kumarasinghe MP, Johansson M, Ee HC, Yeoh G, Mou L, Ferrara KW, Billiran H, Ganss R, Ruoslahti E, Hamzah J. Yeow YL, et al. Among authors: larma i. EMBO Mol Med. 2019 Dec;11(12):e10923. doi: 10.15252/emmm.201910923. Epub 2019 Nov 11. EMBO Mol Med. 2019. PMID: 31709774 Free PMC article.
Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growth.
van der Most RG, Currie AJ, Cleaver AL, Salmons J, Nowak AK, Mahendran S, Larma I, Prosser A, Robinson BW, Smyth MJ, Scalzo AA, Degli-Esposti MA, Lake RA. van der Most RG, et al. Among authors: larma i. PLoS One. 2009 Sep 10;4(9):e6982. doi: 10.1371/journal.pone.0006982. PLoS One. 2009. PMID: 19746156 Free PMC article.
12 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page